Promoters file annual disclosure confirming no share encumbrance in FY26

Promoters of Jagsonpal Pharmaceuticals have filed annual disclosures under SEBI Regulation 31(4) for the financial year ending March 31, 2026. Two separate declarations, one by Infinity Holdings and another by Rajpal Singh Kochhar along with Aresko Progressive Private Limited, confirm that the promoter and promoter group members did not create any encumbrance or pledge on the company's shares directly or indirectly during the year. The disclosure lists 38 promoter and promoter group entities, with key holdings of 30,30,400 shares by Rajpal Singh Kochhar and 1,33,35,635 shares by Aresko Progressive Private Limited acting as trustee.